<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-15.7.1'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//pharminent.com/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://pharminent.com/cordenpharma-inks-ambiopharm-buyout-to-continue-peptide-production-expansion/</loc>
  <lastmod>2026-06-01T15:26:41Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>CordenPharma inks AmbioPharm buyout to continue peptide production expansion</news:title>
   <news:publication_date>2026-06-01T14:30:25Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/servier-wagers-2-65bn-on-edgewise-muscular-dystrophy-drug/</loc>
  <lastmod>2026-06-01T15:26:46Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Servier wagers $2.65bn on Edgewise muscular dystrophy drug</news:title>
   <news:publication_date>2026-06-01T14:26:18Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/asco-summit-reached-with-china-lung-data-but-new-climb-begins-to-prove-global-benefit/</loc>
  <lastmod>2026-06-01T15:26:49Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>ASCO: Summit reached with China lung data but new climb begins to prove global benefit</news:title>
   <news:publication_date>2026-06-01T13:35:50Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/lilly-and-hanmi-sign-1-26bn-licensing-deal-for-sonefpeglutide/</loc>
  <lastmod>2026-06-01T15:29:49Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Lilly and Hanmi sign $1.26bn licensing deal for sonefpeglutide</news:title>
   <news:publication_date>2026-06-01T09:43:03Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/fda-approves-astrazenecas-imfinzi-bcg-combination-for-nmibc-therapy-2/</loc>
  <lastmod>2026-06-01T15:26:53Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>FDA approves AstraZeneca&amp;#039;s Imfinzi-BCG combination for NMIBC therapy</news:title>
   <news:publication_date>2026-06-01T07:36:34Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/oncology/oncology-intelligence-digest-asco-2026-special-edition-mid-meeting-coverage/</loc>
  <lastmod>2026-05-31T20:13:39Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Oncology Intelligence Digest • ASCO 2026 Special Edition • Mid-Meeting Coverage</news:title>
   <news:publication_date>2026-05-31T19:50:53Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/market-access/market-access-quarterly-deep-dive-q2-2026-pbm-exclusions/</loc>
  <lastmod>2026-05-31T19:23:36Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Market Access Quarterly Deep Dive Q2 2026 PBM Exclusions</news:title>
   <news:publication_date>2026-05-31T19:23:32Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/week-in-review/week-in-review-intelligence-brief-may-30-2026/</loc>
  <lastmod>2026-05-30T21:40:35Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Week in Review • INTELLIGENCE BRIEF • May 30, 2026</news:title>
   <news:publication_date>2026-05-30T21:40:30Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/membership-account/your-profile/</loc>
  <lastmod>2026-05-30T16:29:22Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Your Profile</news:title>
   <news:publication_date>2026-05-30T16:29:22Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/membership-levels/</loc>
  <lastmod>2026-05-30T16:29:20Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Membership Levels</news:title>
   <news:publication_date>2026-05-30T16:29:20Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/membership-checkout/membership-confirmation/</loc>
  <lastmod>2026-05-30T16:29:19Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Membership Confirmation</news:title>
   <news:publication_date>2026-05-30T16:29:19Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/membership-account/membership-orders/</loc>
  <lastmod>2026-05-30T16:29:19Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Membership Orders</news:title>
   <news:publication_date>2026-05-30T16:29:19Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/membership-checkout/</loc>
  <lastmod>2026-05-30T16:29:18Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Membership Checkout</news:title>
   <news:publication_date>2026-05-30T16:29:18Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/membership-account/membership-cancel/</loc>
  <lastmod>2026-05-30T16:29:16Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Membership Cancel</news:title>
   <news:publication_date>2026-05-30T16:29:16Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/membership-account/membership-billing/</loc>
  <lastmod>2026-05-30T16:29:14Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Membership Billing</news:title>
   <news:publication_date>2026-05-30T16:29:14Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/membership-account/</loc>
  <lastmod>2026-05-30T16:29:12Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Membership Account</news:title>
   <news:publication_date>2026-05-30T16:29:12Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/market-access/market-access-intelligence-weekly-digest-may-29-2026/</loc>
  <lastmod>2026-05-30T15:27:16Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>MARKET ACCESS INTELLIGENCE • Weekly Digest • May 29, 2026</news:title>
   <news:publication_date>2026-05-30T15:27:12Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/oncology/oncology-intelligence-digest-may-29-2026/</loc>
  <lastmod>2026-05-30T15:22:05Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Oncology Intelligence Digest • May 29, 2026</news:title>
   <news:publication_date>2026-05-30T15:22:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>
